🔎 Trials Near Me

Utama › Neuroblastoma › Arkansas

Kajian klinikal Neuroblastoma di Arkansas

6 kajian untuk Neuroblastoma sedang mencari peserta di lokasi di Arkansas.

Bandar di Arkansas

Teks kajian rasmi (Bahasa Inggeris)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Arkansas Children's Hospital, Little Rock
Mengambil pesertaFasa 3
Sehingga umur 30 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • Arkansas Children's Hospital, Little Rock
Mengambil pesertaFasa 2
Sehingga umur 22 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT02559778

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • Arkansas Children's Hospital, Little Rock
Mengambil pesertaFasa 1/2
Sehingga umur 26 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06465199

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

  • Arkansas Children's Hospital, Little Rock
Mengambil pesertaFasa 2
Umur 1 hingga 21 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06540963

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Arkansas Children's Hospital, Little Rock
Mengambil pesertaFasa 3
365 Days – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT03126916

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • Arkansas Children's Hospital, Little Rock
Mengambil pesertaFasa 2
12 Months – 21 Years · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT05489887

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.